Form 4 for SOPH SOPHiA GENETICS SA
Accepted 2026-09-22 16:02:10 ET · period of report 2026-09-21 · accession 0001840706-26-000318 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-09-22 16:02 | 2026-09-21 | SOPH | CARDOZA GEORGE | CFO | S - Sale | $8.33 | -774 | 308.3K | -0.3% | -$6,447 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-09-21 | S | D | 774 | $8.33 | 308,318 | D | — | — | (F1) Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on September 18, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades. |